HPC
FLNA

HM Payson & Co’s Filana Therapeutics FLNA Stock Holding History

HM Payson & Co’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60 Hold
50
– – ﹤0.01% 1131
2026
Q1 		$85 Hold
50
– – ﹤0.01% 1114
2025
Q4 		$99 Hold
50
– – ﹤0.01% 1139
2025
Q3 		$146 Hold
50
– – ﹤0.01% 1084
2025
Q2 		$91 Hold
50
– – ﹤0.01% 990
2025
Q1 		$75 Hold
50
– – ﹤0.01% 1030
2024
Q4 		$118 Hold
50
– – ﹤0.01% 1024
2024
Q3 		$1.47K Hold
50
– – ﹤0.01% 997
2024
Q2 		$618 Hold
50
– – ﹤0.01% 965
2024
Q1 		$1.01K Hold
50
– – ﹤0.01% 924
2023
Q4 		$1.13K Hold
50
– – ﹤0.01% 925
2023
Q3 		$832 Hold
50
– – ﹤0.01% 968
2023
Q2 		$1.23K Hold
50
– – ﹤0.01% 944
2023
Q1 		$1.21K Hold
50
– – ﹤0.01% 952
2022
Q4 		$1.48K Sell
50
-46
-48% -$1.65K ﹤0.01% 870
2022
Q3 		$4K Buy
96
+25
+35% +$675 ﹤0.01% 870
2022
Q2 		$2K Hold
71
– – ﹤0.01% 970
2022
Q1 		$3K Buy
71
+6
+9% +$254 ﹤0.01% 951
2021
Q4 		$3K Hold
65
– – ﹤0.01% 996
2021
Q3 		$4K Buy
65
+20
+44% +$1.67K ﹤0.01% 931
2021
Q2 		$4K Buy
45
+27
+150% +$1.45K ﹤0.01% 921
2021
Q1 		$1K Buy
+18
New +$708 ﹤0.01% 1105

Other funds holding FLNA

AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
SWA
SOA Wealth Advisors New York $595M AUM 25.98% 1-Year Est. Return
GSWM
Golden State Wealth Management Santa Ana, California $1.1B AUM 27.49% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

HM Payson & Co's FLNA Position: Q2 2026 in Review

HM Payson & Co held its Filana Therapeutics (FLNA) position steady in Q2 2026 at 50 shares worth $60. The position accounts for ﹤0.01% of the portfolio, ranked #1131.

HM Payson & Co first reported a position in FLNA in Q1 2021 and has held it in 22 quarters since. The position peaked at $4K in Q3 2022. 14 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • HM Payson & Co held 50 shares of Filana Therapeutics worth $60 as of Q2 2026.
  • HM Payson & Co left its Filana Therapeutics share count unchanged in Q2 2026.
  • Filana Therapeutics made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #1131 holding.
  • HM Payson & Co first reported a position in Filana Therapeutics in Q1 2021 and has held it in 22 quarters since.
  • HM Payson & Co's Filana Therapeutics position peaked at $4K in Q3 2022.
  • 14 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.